Document is current
Any future updates will be listed below
-
Authors
Cuypers, Marie-Lynn
Jaspers, Tom
Clerckx, Jarne
Leekens, Simon
Cawthorne, Christopher
Bormans, Guy
Cleeren, Frederik
Geukens, Nick
De Strooper, Bart
Dewilde, Maarten
-
Funding
Funding for this research was provided by:
KU Leuven (C3/23/069, C3/23/069, C3/23/069, C3/23/069)
Fonds Wetenschappelijk Onderzoek (11K8122N, AKUL15-30/G0H1216N, G.0929.15)
Vlaamse regering (AKUL/15/37_GOH1816N)
- License Information
-
More Information
Article History
Received: 27 September 2024
Accepted: 20 January 2025
First Online: 30 January 2025
Declarations
:
: All animal experiments were approved by the KU Leuven Animal Ethics Committee (project P091/2022 and P038/2024) following governmental and EU guidelines.
: The data presented in this study are openly available in KU Leuven Research Data Repository (RDR) at 10.48804/JT11HB [].
: The VHH protein sequences can be provided by the laboratory of therapeutic and diagnostic antibodies pending scientific review and a completed material transfer agreement. Requests for the VHH protein sequences should be submitted to: maarten.dewilde@kuleuven.be.
: M.C., T.J., B.D.S, and M.D. declare to be holder of patent EP23198043.4. Apart thereof, the authors declare that they have no further competing interests
